Cloning and characterization of a novel gene, DRH1, down-regulated in advanced human hepatocellular carcinoma

Y. Yamamoto, Michiie Sakamoto, G. Fujii, K. Kanetaka, M. Asaka, S. Hirohashi

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Few genes related to carcinogenesis and progression of hepatocellular carcinoma (HCC) have been identified to date. In the present study, we report the cloning and characterization of a novel gene, DRH1, which is frequently down-regulated in HCC. The full-length DRH1 clone contains an open reading frame of 1257 nucleotides encoding 419 amino acids. The deduced DRH1 protein shows 41% identity to VDUP1, expression of which is rapidly induced by 1,25-dihydroxyvitamin D3. The DRH1 gene was localized to chromosome 15, and DRH1 protein was mainly observed in the cytoplasm of transiently transfected cells. Real-time quantitative reverse transcription-PCR analysis showed that the expression level of DRH1 was reduced in 29 of 35 (83%) HCCs compared with corresponding noncancerous liver tissue. The average (mean ± SE) ratio of DRH1 expression level in tumor to corresponding noncancerous tissue was significantly different between well, moderately, and poorly differentiated HCCs (1.15 ± 0.23, 0.69 ± 0.10, and 0.19 ± 0.04, respectively) and between HCCs without and with vascular invasion (0.94 ± 0.16 and 0.46 ± 0.07, respectively). These results indicate that the down-regulation of DRH1 occurs not at an early stage but rather at a late stage of HCC progression. Although the function of DRH1 protein is still unknown, our findings suggest that DRH1 is related to the progression of HCC and may provide a new prognostic factor.

Original languageEnglish
Pages (from-to)297-303
Number of pages7
JournalClinical Cancer Research
Volume7
Issue number2
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Organism Cloning
Hepatocellular Carcinoma
Genes
Chromosomes, Human, Pair 15
Proteins
Calcitriol
Open Reading Frames
Reverse Transcription
Blood Vessels
Carcinogenesis
Cytoplasm
Down-Regulation
Nucleotides
Clone Cells
Amino Acids
Polymerase Chain Reaction
Liver
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Cloning and characterization of a novel gene, DRH1, down-regulated in advanced human hepatocellular carcinoma. / Yamamoto, Y.; Sakamoto, Michiie; Fujii, G.; Kanetaka, K.; Asaka, M.; Hirohashi, S.

In: Clinical Cancer Research, Vol. 7, No. 2, 2001, p. 297-303.

Research output: Contribution to journalArticle

Yamamoto, Y, Sakamoto, M, Fujii, G, Kanetaka, K, Asaka, M & Hirohashi, S 2001, 'Cloning and characterization of a novel gene, DRH1, down-regulated in advanced human hepatocellular carcinoma', Clinical Cancer Research, vol. 7, no. 2, pp. 297-303.
Yamamoto, Y. ; Sakamoto, Michiie ; Fujii, G. ; Kanetaka, K. ; Asaka, M. ; Hirohashi, S. / Cloning and characterization of a novel gene, DRH1, down-regulated in advanced human hepatocellular carcinoma. In: Clinical Cancer Research. 2001 ; Vol. 7, No. 2. pp. 297-303.
@article{bf4d95ab49fd4d4aa6df5d8b115eed05,
title = "Cloning and characterization of a novel gene, DRH1, down-regulated in advanced human hepatocellular carcinoma",
abstract = "Few genes related to carcinogenesis and progression of hepatocellular carcinoma (HCC) have been identified to date. In the present study, we report the cloning and characterization of a novel gene, DRH1, which is frequently down-regulated in HCC. The full-length DRH1 clone contains an open reading frame of 1257 nucleotides encoding 419 amino acids. The deduced DRH1 protein shows 41{\%} identity to VDUP1, expression of which is rapidly induced by 1,25-dihydroxyvitamin D3. The DRH1 gene was localized to chromosome 15, and DRH1 protein was mainly observed in the cytoplasm of transiently transfected cells. Real-time quantitative reverse transcription-PCR analysis showed that the expression level of DRH1 was reduced in 29 of 35 (83{\%}) HCCs compared with corresponding noncancerous liver tissue. The average (mean ± SE) ratio of DRH1 expression level in tumor to corresponding noncancerous tissue was significantly different between well, moderately, and poorly differentiated HCCs (1.15 ± 0.23, 0.69 ± 0.10, and 0.19 ± 0.04, respectively) and between HCCs without and with vascular invasion (0.94 ± 0.16 and 0.46 ± 0.07, respectively). These results indicate that the down-regulation of DRH1 occurs not at an early stage but rather at a late stage of HCC progression. Although the function of DRH1 protein is still unknown, our findings suggest that DRH1 is related to the progression of HCC and may provide a new prognostic factor.",
author = "Y. Yamamoto and Michiie Sakamoto and G. Fujii and K. Kanetaka and M. Asaka and S. Hirohashi",
year = "2001",
language = "English",
volume = "7",
pages = "297--303",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "2",

}

TY - JOUR

T1 - Cloning and characterization of a novel gene, DRH1, down-regulated in advanced human hepatocellular carcinoma

AU - Yamamoto, Y.

AU - Sakamoto, Michiie

AU - Fujii, G.

AU - Kanetaka, K.

AU - Asaka, M.

AU - Hirohashi, S.

PY - 2001

Y1 - 2001

N2 - Few genes related to carcinogenesis and progression of hepatocellular carcinoma (HCC) have been identified to date. In the present study, we report the cloning and characterization of a novel gene, DRH1, which is frequently down-regulated in HCC. The full-length DRH1 clone contains an open reading frame of 1257 nucleotides encoding 419 amino acids. The deduced DRH1 protein shows 41% identity to VDUP1, expression of which is rapidly induced by 1,25-dihydroxyvitamin D3. The DRH1 gene was localized to chromosome 15, and DRH1 protein was mainly observed in the cytoplasm of transiently transfected cells. Real-time quantitative reverse transcription-PCR analysis showed that the expression level of DRH1 was reduced in 29 of 35 (83%) HCCs compared with corresponding noncancerous liver tissue. The average (mean ± SE) ratio of DRH1 expression level in tumor to corresponding noncancerous tissue was significantly different between well, moderately, and poorly differentiated HCCs (1.15 ± 0.23, 0.69 ± 0.10, and 0.19 ± 0.04, respectively) and between HCCs without and with vascular invasion (0.94 ± 0.16 and 0.46 ± 0.07, respectively). These results indicate that the down-regulation of DRH1 occurs not at an early stage but rather at a late stage of HCC progression. Although the function of DRH1 protein is still unknown, our findings suggest that DRH1 is related to the progression of HCC and may provide a new prognostic factor.

AB - Few genes related to carcinogenesis and progression of hepatocellular carcinoma (HCC) have been identified to date. In the present study, we report the cloning and characterization of a novel gene, DRH1, which is frequently down-regulated in HCC. The full-length DRH1 clone contains an open reading frame of 1257 nucleotides encoding 419 amino acids. The deduced DRH1 protein shows 41% identity to VDUP1, expression of which is rapidly induced by 1,25-dihydroxyvitamin D3. The DRH1 gene was localized to chromosome 15, and DRH1 protein was mainly observed in the cytoplasm of transiently transfected cells. Real-time quantitative reverse transcription-PCR analysis showed that the expression level of DRH1 was reduced in 29 of 35 (83%) HCCs compared with corresponding noncancerous liver tissue. The average (mean ± SE) ratio of DRH1 expression level in tumor to corresponding noncancerous tissue was significantly different between well, moderately, and poorly differentiated HCCs (1.15 ± 0.23, 0.69 ± 0.10, and 0.19 ± 0.04, respectively) and between HCCs without and with vascular invasion (0.94 ± 0.16 and 0.46 ± 0.07, respectively). These results indicate that the down-regulation of DRH1 occurs not at an early stage but rather at a late stage of HCC progression. Although the function of DRH1 protein is still unknown, our findings suggest that DRH1 is related to the progression of HCC and may provide a new prognostic factor.

UR - http://www.scopus.com/inward/record.url?scp=0035127260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035127260&partnerID=8YFLogxK

M3 - Article

C2 - 11234883

AN - SCOPUS:0035127260

VL - 7

SP - 297

EP - 303

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 2

ER -